May 5, 2025, 13:10

ACPMP Changemaker Grant: Advancing Research in Appendix Cancer and PMP

The ACPMP Research Foundation is now accepting applications for its 2025 Changemaker Research Grant, designed to fund high-impact research in appendix cancer and pseudomyxoma peritonei (PMP). This rare disease-focused award seeks scientific, clinical, or translational projects with strong potential to transform understanding or treatment of appendiceal malignancies.

Who is eligible?

Applicants must hold a doctoral degree (PhD, MD, MD/PhD, or equivalent) and a full-time faculty appointment at the rank of Assistant Professor or higher. Eligible institutions include academic, medical, or research organizations. Only one proposal per applicant is allowed per cycle. Applicants currently funded by an ACPMP Catalyst Grant are ineligible.

Funding at a glance:

150,000 USD total in direct costs (no indirect costs allowed)
Must adhere to NIH salary cap
Funding cannot be used for professional memberships, conference attendance, tuition, or for-profit/government salaries
Proposals should justify budget and percent effort of all key personnel

Research focus:

The Foundation prioritizes proposals aligned with its Think Tank core research areas, including:

Histopathologic classification of appendix tumors
Tumor microenvironment characterization
Molecular profiling and therapeutic targeting
Disease modeling and repositories
Clinical trials and population-level studies

Eligible cancer types include appendiceal mucinous neoplasms, appendiceal adenocarcinomas (e.g., signet ring cell, goblet cell), and PMP of appendiceal origin.

Key deadlines:

Full Application Deadline: September 1, 2025 (5:00 p.m. EST)
Review Period: October–November 2025
Award Notification: November 2025
Grant Term Start Date: December 1, 2025

Where to apply:

Applications must be submitted through ProposalCentral. For inquiries, contact: [email protected]

ACPMP ACPMP Research Foundation Appendix Cancer cancer cancer research funding Changemaker Grant histopathologic classification OncoDaily Oncology peritoneal malignancies proposalCENTRAL Pseudomyxoma peritonei Rare Cancers translational research tumor microenvironment

Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology

How Artificial Intelligence Is Transforming Cancer Care in 2025: Diagnosis, Treatment, Clinical Trials, and Screening

Inside ASCO25 Exhibition - Who did it the best?

Douglas Flora: Fighting Cancer with Heart